ClinicalTrials.gg
Not yet recruitingNCT07859891SHOULD-ERUpdated Oct 6, 2026

Personalised Education Versus Usual Physiotherapy for Acute Rotator Cuff-Related Shoulder Pain

An interventional study of Personalised, Multimodal Educational Intervention and Usual Physiotherapy Care in Rotator Cuff-related Shoulder Pain, Shoulder Pain and Shoulder Disability, sponsored by Centre Hospitalier Régional d'Orléans. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Centre Hospitalier Régional d'Orléans · Not applicable, Interventional, and Treatment

How we know

Updated Oct 6, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
118
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Shoulder Pain with a site in France — 3 open to participants now, 3 under way, none of them phase 3. Shoulder Pain · France.

Started
2026
with 1 other
No phase
9 of 10
3 open now
Registered
9th of 10
by date
Lead sponsor
1 of 10
Centre Hospitalier Régional d'Orléans

Among the 10 studies in Shoulder Pain with a site in France, this one is one of 2 that started in 2026, is one of 9 with no phase, and was the 9th registered.

Shoulder Pain

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

3 of the 10 studies in Shoulder Pain with a site in France are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Shoulder Pain with a site in France, or all of them as a file.
02

Study summary

Rotator cuff-related shoulder pain (RCRSP) is one of the most common musculoskeletal disorders presenting in primary care. It is frequently associated with persistent pain, disability, healthcare utilisation and work absenteeism. Exercise-based physiotherapy is recommended as first-line management in clinical practice guidelines, yet its average effects on pain and disability are modest and a substantial proportion of people remain symptomatic several months after onset. Patient education is also recommended, and trials conducted in people with persistent symptoms suggest that education-based care may produce improvements comparable to those obtained with progressive exercise. However, the effectiveness of a structured educational intervention as a first-line management strategy during the acute phase of RCRSP remains unclear.

SHOULD Education lead Rehabilitation? (SHOULD-ER) is a multicentre, pragmatic, parallel-group, non-inferiority randomised controlled trial comparing a personalised, multimodal educational intervention with usual physiotherapy care in adults presenting with acute non-traumatic RCRSP of less than six weeks duration. Participants will be randomly assigned to one of the trial arms for a 12-week treatment period, with follow-up to 24 weeks.

The primary objective is to determine whether the educational intervention is non-inferior to usual physiotherapy care regarding improvement in shoulder pain and disability at 12 weeks, measured by the Shoulder Pain and Disability Index (SPADI). Secondary outcomes include pain-related function, self-efficacy, fear-avoidance beliefs, quality of life, sleep quality, patient satisfaction and healthcare costs.

A nested qualitative study and a within-trial economic evaluation are embedded in the trial. An exploratory analysis of prognostic factors will also be conducted with a secondary analysis.

Read the detailed description

This multicentre pragmatic randomized controlled non-inferiority trial will recruit 118 adults with acute non-traumatic rotator cuff-related shoulder pain of less than six weeks duration.

Participants will be randomly allocated (1:1) to one of two treatment groups:

Experimental group: Personalised, multimodal educational intervention. Control group: Usual physiotherapy care. Participants allocated to the experimental strategy will receive a personalised, multimodal educational intervention. The intervention targets understanding of shoulder anatomy and function, understanding of the condition, reassurance through contemporary explanations of pain, identification and modification of unhelpful pain-related beliefs and responses, pain self-efficacy, recovery expectations, graded exposure to physical activity and daily activities, and health literacy. It may be delivered through a written educational guide, a study website hosting video resources, and individual educational consultations, in combinations agreed between participant and physiotherapist through shared decision making.

The control group will receive routine physiotherapy management according to current clinical practice and clinical guidelines. Treatment may combine therapeutic exercise, verbal education, manual therapy and other adjunctive treatments in routine use, at the discretion of the treating physiotherapist. Therapeutic exercise is expected to be the central component and is what distinguishes the comparator from the experimental strategy.

Assessments will be performed at baseline, 6 weeks, 12 weeks and 24 weeks. The primary endpoint is change in the Shoulder Pain and Disability Index (SPADI) score at 12 weeks. Secondary outcomes include physical function, pain self-efficacy, fear-avoidance beliefs, health-related quality of life, sleep quality, patient acceptable symptom state, treatment satisfaction and direct and indirect healthcare costs.

The first 10 months of recruitment form an internal pilot phase with prespecified progression criteria: rate of screened participants who consent to participate in the trial, number of participants recruited, number of centres that recruited at least 3 participants over a 10-month period.

03

Conditions studied

  • Rotator Cuff-related Shoulder Pain
  • Shoulder Pain
  • Shoulder Disability

Browse trials for

Keywords

  • Rotator Cuff-Related Shoulder Pain
  • Shoulder Pain
  • Patient Education
  • Physiotherapy
  • Self-Management
  • Primary Health Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years
  • Able to speak and understand French
  • Affiliated with a French health insurance system
  • Available for study follow-up
  • Clinical diagnosis of acute non-traumatic rotator cuff-related shoulder pain of less than 6 weeks' duration: deltoid-region and/or upper arm pain; pain associated with arm movement; familiar pain reproduced during resisted external rotation testing
  • Written obtained

Exclusion criteria

Exclusion Criteria:

  • Previous traumatic shoulder injury potentially causing rotator cuff tear, capsuloligamentous or labral injury, fracture, or dislocation involving the shoulder complex
  • Clinical signs of massive rotator cuff tear
  • Referred or cervical radicular pain
  • Cervical radiculopathy, neuropathic pain or upper-limb neuropathy
  • Frozen shoulder
  • Glenohumeral instability
  • Glenohumeral, acromioclavicular, or sternoclavicular arthropathy
  • Vascular disorders affecting the upper limb
  • Inflammatory rheumatic disease affecting the upper limb
  • Central neurological disease or cancer affecting the shoulder
  • Previous surgery on the painful shoulder
  • Current rehabilitation for the present shoulder episode
  • Opioid use or injection within 3 months or planned at the enrolment
  • Unable to complete questionnaires
  • Participation in another clinical trial
  • Persons under legal protection
  • Administrative or judicial supervision
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
118 participants (estimated)

Study arms

  • Experimental
    Personalised, Multimodal Educational Intervention

    Participants receive a personalised educational intervention including educational materials, digital resources and up to eight consultations with a physiotherapist during a 12-week intervention period.

    Behavioral: Personalised, Multimodal Educational Intervention

  • Active comparator
    Usual Physiotherapy Care

    Participants receive up to eight consultations routine physiotherapy management for acute rotator cuff-related shoulder pain according to current clinical practice.

    Behavioral: Usual Physiotherapy Care

Interventions

  • BehavioralPersonalised, Multimodal Educational Intervention

    Participants receive a personalised, multimodal educational intervention over a maximum of 12 weeks. Delivery may combine a written educational guide, a study website hosting video resources, and up to eight individual educational consultations of approximately 30 minutes. The content and the combination of components are agreed between participant and physiotherapist through shared decision making. No structured therapeutic exercise programme is prescribed, and participants in this group do not receive usual physiotherapy care in addition. The intervention aims to improve understanding of shoulder pain, self-management skills, confidence in movement and return to normal activities.

  • BehavioralUsual Physiotherapy Care

    Participants receive usual physiotherapy care over a maximum of 12 weeks, comprising up to eight supervised consultations of approximately 30 minutes delivered according to current clinical practice. Treatment may combine therapeutic exercise, verbal education, manual therapy and other adjunctive treatments in routine use, at the discretion of the treating physiotherapist.

06

What researchers measure

Primary outcomes

  1. Change in Shoulder Pain and Disability Index (SPADI) total Score

    The Shoulder Pain and Disability Index (SPADI) is a 13-item participant-reported questionnaire comprising a five-item pain subscale and an eight-item disability subscale. Items are combined and transformed into a total score ranging from 0 to 100, with higher scores indicating greater shoulder pain and disability. The primary endpoint is the between-group difference in SPADI score change from baseline to Week 12.

    Time frame: Baseline to Week 12

Secondary outcomes

  1. Shoulder Pain and Disability Index (SPADI) total score trajectory

    Longitudinal course of the SPADI total score, scored from 0 to 100 with higher scores indicating greater shoulder pain and disability.

    Time frame: Baseline, Week 6, Week 12, and Week 24

  2. Patient-Specific Functional Scale (PSFS)

    Participants nominate activities they find difficult because of their shoulder and rate each from 0 to 10, with higher scores indicating greater ability to perform the activity.

    Time frame: Baseline, Week 6, Week 12, and Week 24

  3. Pain Self-Efficacy Questionnaire (PSEQ)

    The PSEQ comprises 10 items rated from 0 to 6, giving a total score from 0 to 60, with higher scores indicating greater confidence in performing activities despite pain

    Time frame: Baseline, Week 6, Week 12, and Week 24

  4. Fear-Avoidance Beliefs Questionnaire - Physical activity subscale (FABQ-PA)

    The FABQ-PA measures beliefs about the effect of physical activity on shoulder pain, with higher scores indicating stronger fear-avoidance beliefs.

    Time frame: Baseline, Week 6, Week 12, and Week 24

  5. Health-Related Quality of Life (EQ-5D-5L)

    The EQ-5D-5L assesses mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Health states are converted into utility scores using the French value set.

    Time frame: Baseline, Week 6, Week 12, and Week 24

  6. Pittsburgh Sleep Quality Index (PSQI)

    The PSQI generates a global score from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline, Week 6, Week 12 and Week 24

  7. Patient Acceptable Symptom State (PASS) at 12 weeks

    The Patient Acceptable Symptom State (PASS) determines whether participants consider their current symptom level acceptable. The proportion of participants achieving PASS will be compared between groups.

    Time frame: Week 12

  8. Patient Satisfaction With Treatment at 12 weeks

    Eight items covering respect for values, preferences and needs; coordination and integration of care; information, communication and education; physical comfort; emotional support; involvement of family and relatives; transition and continuity of care; and accessibility of care. Each item is rated from not at all satisfied to completely satisfied, with a not applicable option

    Time frame: Week 12

  9. Direct Healthcare Costs

    Direct healthcare resource use related to shoulder pain, comprising physiotherapy consultations, shoulder-related imaging investigations, prescribed medications and consultations with other healthcare professionals, valued using French statutory health insurance tariffs. The reported metric is the mean cost per participant in each group.

    Time frame: Baseline to Week 24

  10. Indirect Costs and Work Productivity Loss

    Productivity losses arising from work absence attributable to shoulder pain, estimated from the number of workdays lost and self-reported gross income among participants in remunerated employment or self-employment. The reported metric is the mean cost per participant in each group.

    Time frame: Baseline to Week 24

07

Study locations

1 site
  • Laboratoire Sport Activité Physique Rééducation et Motricité pour la performance et la santé (SAPRéM)
    Orléans, Loiret 45067, France
08

References and documents

Publications

  • Braun, V., & Clarke, V. (2021). To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Research in Sport, Exercise and Health, 13(2), 201-216. https://doi.org/10.1080/2159676X.2019.1704846
  • Braun, V., & Clarke, V. (2013). Successful Qualitative Research : A Practical Guide for Beginners. SAGE.
  • Braun, V., & Clarke, V. (2022). Thematic analysis : A practical guide. SAGE.
  • Buchbinder R, Ramiro S, Huang H, Gagnier JJ, Jia Y, Whittle SL. Measures of Adult Shoulder Function. Arthritis Care Res (Hoboken). 2020 Oct;72 Suppl 10:250-293. doi: 10.1002/acr.24230. No abstract available. PubMed 33091271 ↗
  • Bigliani LU, Ticker JB, Flatow EL, Soslowsky LJ, Mow VC. The relationship of acromial architecture to rotator cuff disease. Clin Sports Med. 1991 Oct;10(4):823-38. PubMed 1934099 ↗
  • Bell ML, Whitehead AL, Julious SA. Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes. Clin Epidemiol. 2018 Jan 18;10:153-157. doi: 10.2147/CLEP.S146397. eCollection 2018. PubMed 29403314 ↗
  • Bedi A, Bishop J, Keener J, Lansdown DA, Levy O, MacDonald P, Maffulli N, Oh JH, Sabesan VJ, Sanchez-Sotelo J, Williams RJ 3rd, Feeley BT. Rotator cuff tears. Nat Rev Dis Primers. 2024 Feb 8;10(1):8. doi: 10.1038/s41572-024-00492-3. PubMed 38332156 ↗
  • Babatunde OO, Ensor J, Littlewood C, Chesterton L, Jordan JL, Corp N, Wynne-Jones G, Roddy E, Foster NE, van der Windt DA. Comparative effectiveness of treatment options for subacromial shoulder conditions: a systematic review and network meta-analysis. Ther Adv Musculoskelet Dis. 2021 Sep 9;13:1759720X211037530. doi: 10.1177/1759720X211037530. eCollection 2021. PubMed 34527083 ↗
  • Axelsson E. Equivalence and non-inferiority trials in the evaluation of non-pharmacological interventions: rationale, challenges and recommendations. BMJ Open. 2025 Aug 31;15(8):e102996. doi: 10.1136/bmjopen-2025-102996. PubMed 40887112 ↗
  • ARMSTRONG JR. The supraspinatus syndrome. Lancet. 1947 Jan 18;1(6438):94-6. doi: 10.1016/s0140-6736(47)91045-3. No abstract available. PubMed 20281016 ↗
  • Andrade LF, Ludwig K, Goni JMR, Oppe M, de Pouvourville G. A French Value Set for the EQ-5D-5L. Pharmacoeconomics. 2020 Apr;38(4):413-425. doi: 10.1007/s40273-019-00876-4. PubMed 31912325 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jul 2029, 33 months later.

Of 351 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 33 months is above that.

Counting every sponsor, half of 356 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2026
First posted
Oct 6, 2026
StartEst.
Oct 17, 2026
Primary completionEst.
Jul 17, 2029
CompletionEst.
Oct 17, 2029
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07859891
Responsible party
Sponsor
First posted
Oct 6, 2026
Start date
Oct 17, 2026 (estimated)
Primary completion
Jul 17, 2029 (estimated)
Completion
Oct 17, 2029 (estimated)
Last update
Oct 6, 2026

Study contacts

Alexis RAMOS, PhD
Contact
alexis.ramos@univ-orleans.fr
0666603335 ext. +33
Camille PRIMA--CROCKAERT
Contact
camille.prima@chu-orleans.fr
0238744292 ext. +33
Alexis RAMOS, PhD
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion